IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 13,315

Sort by:

Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major schizophrenia markets reached a value of US$ 9,480.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15,236.9 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Sciatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sciatica markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.62% during...

May 2024 128 pages

Scleroderma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major scleroderma markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The scleroderma market has been comprehensively analyzed in IMARC's new report titled 'Scleroderma Market: Epi...

May 2024 136 pages

Scoliosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major scoliosis markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3% during 20...

May 2024 129 pages

Seasonal Allergic Rhinitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The seasonal allergic rhinitis market reached a value of US$ 10.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$...

May 2024 140 pages

Seasonal Influenza Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seasonal influenza markets reached a value of US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 41.6 Billion by 2034, exhibiting a growth rate (CAGR) of 15...

May 2024 133 pages

Seborrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seborrhea markets are expected to exhibit a CAGR of 7.55% during 2024-2034. The seborrhea market has been comprehensively analyzed in IMARC's new report titled 'Seborrhea Market: Epidemiol...

May 2024 134 pages

Seizures Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seizures markets reached a value of US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.17% during...

May 2024 132 pages

Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sepsis markets reached a value of US$ 438.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 907.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.84% durin...

May 2024 131 pages

Septic Shock Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major septic shock markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The septic shock market has been comprehensively analyzed in IMARC's new report titled 'Septic Shock Market:...

May 2024 128 pages

Severe Acute Respiratory Syndrome Coronavirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major severe acute respiratory syndrome coronavirus infection markets reached a value of US$ 21.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 68.5 Billion by 2034,...

May 2024 129 pages

Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sexually transmitted disease markets reached a value of US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (...

May 2024 128 pages

Sezary Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sezary syndrome markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The Sezary syndrome market has been comprehensively analyzed in IMARC's new report titled 'Sezary Syndrome...

May 2024 140 pages

Short Bowel Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major short bowel syndrome markets are expected to exhibit a CAGR of 20.52% during 2024-2034. The short bowel syndrome market has been comprehensively analyzed in IMARC's new report titled 'Shor...

May 2024 128 pages

Sialidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sialidosis markets are expected to exhibit a CAGR of 6.9% during 2024-2034. The sialidosis market has been comprehensively analyzed in IMARC's new report titled 'Sialidosis Market: Epidemi...

May 2024 134 pages

Sick Sinus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sick sinus syndrome markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 133 pages

Sjogren's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sjogren's syndrome markets reached a value of US$ 168.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 226.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Skin Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major skin neoplasms markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.91% d...

May 2024 139 pages

Sly Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sly syndrome markets reached a value of US$ 670.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 934.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.07%...

May 2024 135 pages

Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major small cell lung cancer markets reached a value of US$ 8.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.1 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 133 pages

Small Lymphocytic Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major small lymphocytic lymphoma markets are expected to exhibit a CAGR of 2.3% during 2024-2034. The small lymphocytic lymphoma market has been comprehensively analyzed in IMARC's new report ti...

May 2024 140 pages

Smoking Cessation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major smoking cessation markets are expected to exhibit a CAGR of 7.32% during 2024-2034. The smoking cessation market has been comprehensively analyzed in IMARC's new report titled 'Smoking Ces...

May 2024 135 pages

Soft Tissue Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major soft tissue neoplasms markets are expected to exhibit a CAGR of 6.07% during 2024-2034. The soft tissue neoplasms market has been comprehensively analyzed in IMARC's new report titled 'Sof...

May 2024 130 pages

Soft Tissue Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major soft tissue sarcoma markets reached a value of US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 133 pages

Solid Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major solid tumors markets reached a value of US$ 170.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 375.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.45%...

May 2024 140 pages

Somatotropin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major somatotropin deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The somatotropin deficiency market has been comprehensively analyzed in IMARC's new report titled...

May 2024 133 pages

Sphingolipidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sphingolipidoses markets are expected to exhibit a CAGR of 4.01% during 2024-2034. The sphingolipidoses market has been comprehensively analyzed in IMARC's new report titled 'Sphingolipido...

May 2024 140 pages

Spina Bifida In Utero Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spina bifida in utero markets are expected to exhibit a CAGR of 6.59% during 2024-2034. The spina bifida in utero market has been comprehensively analyzed in IMARC's new report titled 'Spi...

May 2024 129 pages

Spinal Cord Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal cord injury markets are expected to exhibit a CAGR of 4.06% during 2024-2034. The spinal cord injury market has been comprehensively analyzed in IMARC's new report titled 'Spinal Co...

May 2024 130 pages

Spinal Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal disorders markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.09%...

May 2024 134 pages

Spinal Muscular Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal muscular atrophy markets reached a value of US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.0 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 129 pages

Spinal Stenosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal stenosis markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3.12%...

May 2024 131 pages

Spinocerebellar Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinocerebellar ataxia markets are expected to exhibit a CAGR of 7.45% during 2024-2034. The spinocerebellar ataxia market has been comprehensively analyzed in IMARC's new report titled 'S...

May 2024 140 pages

Spondylolisthesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spondylolisthesis markets reached a value of US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 139 pages

Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major squamous cell carcinoma markets reached a value of US$ 693.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,402.7 Million by 2034, exhibiting a growth rate (C...

May 2024 138 pages

Stargardt Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Stargardt disease markets are expected to exhibit a CAGR of 22.82% during 2024-2034. The Stargardt disease market has been comprehensively analyzed in IMARC's new report titled 'Stargardt...

May 2024 129 pages

Status Epilepticus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major status epilepticus markets reached a value of US$ 884 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,338.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Still's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Still's disease markets are expected to exhibit a CAGR of 3.45% during 2024-2034. The Still's disease market has been comprehensively analyzed in IMARC's new report titled 'Still's Disease...

May 2024 128 pages

Stress Urinary Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major stress urinary incontinence markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The stress urinary incontinence market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Subdural Haematoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major subdural haematoma markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The subdural haematoma market has been comprehensively analyzed in IMARC’s new report titled “Subdural...

May 2024 134 pages

Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major substance use disorder markets reached a value of US$ 5.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 136 pages

Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major surgical site infections markets reached a value of US$ 664.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,174.5 Million by 2034, exhibiting a growth rate (...

May 2024 135 pages

Swimmer's Shoulder/Impingement Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major swimmer's shoulder/impingement syndrome markets are expected to exhibit a CAGR of 5.7% during 2024-2034. The swimmer's shoulder/impingement syndrome market has been comprehensively analyze...

May 2024 137 pages

Synovial Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major synovial sarcoma markets reached a value of US$ 75.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 114.0 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 137 pages

Synucleinopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major synucleinopathies markets reached a value of US$ 661.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,095.2 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 131 pages

Systemic Juvenile Idiopathic Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic juvenile idiopathic arthritis markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,250 Million by 2034, exhibiting a gro...

May 2024 135 pages

Systemic Mastocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic mastocytosis markets reached a value of US$ 256.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 455.5 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Systemic Sclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic sclerosis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.0...

May 2024 137 pages

T-Cell Non-Hodgkin Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major T-cell non-Hodgkin lymphoma markets are expected to exhibit a CAGR of 5.55% during 2024-2034. The T-cell non-Hodgkin lymphoma market has been comprehensively analyzed in IMARC's new report...

May 2024 129 pages

Tachycardia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tachycardia markets reached a value of US$ 9.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.76% dur...

May 2024 135 pages

Filters

Clear all